Table 5.
PP3M characteristics for relapse outcomes on PP3M and PPLAI.
| PP3M | Total | PP3M no relapse | PP3M relapse | PPLAI no relapse | PPLAI relapse | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n = 186 | n = 166 | n = 20 | n = 164 | n = 22 | ||||||
| Average PP3M injections/year | ||||||||||
| Mean, SD | 4.0, 0.1 | 4.0, 0.1 | 4.0, 0.1 | 4.0, 0.1 | 4.0, 0.1 | |||||
| Min, max | 3.6, 4.7 | 3.6, 4.7 | 3.7, 4.2 | 3.6, 4.7 | 3.7, 4.2 | |||||
| Average no. days between PP3M injections | ||||||||||
| Mean, SD | 92, 3.5 | 92, 3.4 | 93, 4.6 | 92, 3.4 | 92, 4.4 | |||||
| Min, max | 70, 106 | 70, 106 | 84, 105 | 70, 106 | 84, 105 | |||||
Abbreviations: PPLAI, paliperidone long-acting injection; PP3M, Paliperidone 3-monthly; SD, standard deviation.